The Architecture Software Market Size, Growth driven by the increasing architect knowledge and increasing demand for sophisticated architectural technologies across construction sectors, growing
Adverse Event Reporting Software Segment to Grow at Highest CAGR During 2020-2027
Pharmacovigilance and Drug Safety Software Market is expected to reach US$ 292.97 Mn in 2027 from US$ 160.67 Mn in 2019. The market is estimated to grow at a CAGR of 7.6% from 2020 to 2027.
The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. Factors such as rising incidences of adverse drug reaction (ADR) and globalization of pharmacovigilance have been boosting the market over the years. However, the expensive technology is likely to have a negative impact on the growth of the market in the coming years.